Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Opiant Pharmaceuticals Inc. (OPNT)

28.8   1.73 (6.39%) 01-19 08:31
Open: 26.69 Pre. Close: 27.07
High: 28.99 Low: 26.66
Volume: 83,455 Market Cap: 136M
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 29.072 - 29.233 29.233 - 29.364
Low: 26.19 - 26.405 26.405 - 26.58
Close: 28.46 - 28.803 28.803 - 29.081

Technical analysis

as of: 2022-01-19 8:23:23 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 38.55     One year: 44.05
Support: Support1: 25.40    Support2: 21.13
Resistance: Resistance1: 33.01    Resistance2: 37.71
Pivot: 31.35
Moving Average: MA(5): 28.91     MA(20): 32.25
MA(100): 26.67     MA(250): 18.66
MACD: MACD(12,26): -0.60     Signal(9): 0.15
Stochastic oscillator: %K(14,3): 28.25     %D(3): 19.85
RSI: RSI(14): 41.50
52-week: High: 37.71  Low: 9.82  Change(%): 186.6
Average Vol(K): 3-Month: 6381  10-Days: 7246

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OPNT has closed above bottom band by 18.3%. Bollinger Bands are 16.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation - Yahoo Finance

Sun, 16 Jan 2022
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Expected to Announce Quarterly Sales of $13.68 Million - MarketBeat

Mon, 03 Jan 2022
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Short Interest Up 67.1% in December - MarketBeat

Mon, 20 Dec 2021
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Thu, 11 Nov 2021
Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update - Yahoo Finance

Wed, 10 Nov 2021
Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 4
% Held by Insiders 8.50
% Held by Institutions 30.03
Shares Short (K) 27
Shares Short P. Month (K) 16

Stock Financials

EPS 0.310
EPS Est This Year 0.500
EPS Est Next Year 1.250
Book Value (p.s.) 9.100
Profit Margin 3.58
Operating Margin 6.53
Return on Assets (ttm) 3.2
Return on Equity (ttm) 4.1
Qtrly Rev. Growth 79.4
Gross Profit (p.s.) 3.006
Sales Per Share 9.303
EBITDA (p.s.) 0.631
Qtrly Earnings Growth 371.30
Operating Cash Flow (M) -2
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio 92.90
PEG Ratio
Price to Book value 3.16
Price to Sales 3.10
Price to Cash Flow -79.49

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.